Emmaus Life Sciences Probability of Future OTC Stock Price Finishing Under 0.37
Emmaus Life's future price is the expected price of Emmaus Life instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Emmaus Life Sciences performance during a given time horizon utilizing its historical volatility. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in population.
Please specify Emmaus Life's target price for which you would like Emmaus Life odds to be computed.
Emmaus |
Emmaus Life Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Emmaus Life for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Emmaus Life Sciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.Emmaus Life Sciences is not yet fully synchronised with the market data | |
Emmaus Life Sciences has some characteristics of a very speculative penny stock | |
Emmaus Life Sciences has a very high chance of going through financial distress in the upcoming years | |
Emmaus Life Sciences currently holds 4.65 M in liabilities. Emmaus Life Sciences has a current ratio of 0.14, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Emmaus Life until it has trouble settling it off, either with new capital or with free cash flow. So, Emmaus Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Emmaus Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Emmaus to invest in growth at high rates of return. When we think about Emmaus Life's use of debt, we should always consider it together with cash and equity. | |
The entity reported the previous year's revenue of 20.61 M. Net Loss for the year was (15.95 M) with profit before overhead, payroll, taxes, and interest of 17.3 M. | |
Emmaus Life Sciences currently holds about 982 K in cash with (1.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02. | |
Roughly 39.0% of the company shares are held by company insiders |
Emmaus Life Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Emmaus OTC Stock often depends not only on the future outlook of the current and potential Emmaus Life's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Emmaus Life's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 49.3 M | |
Cash And Short Term Investments | 2.3 M |
Emmaus Life Technical Analysis
Emmaus Life's future price can be derived by breaking down and analyzing its technical indicators over time. Emmaus OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Emmaus Life Sciences. In general, you should focus on analyzing Emmaus OTC Stock price patterns and their correlations with different microeconomic environments and drivers.
Emmaus Life Predictive Forecast Models
Emmaus Life's time-series forecasting models is one of many Emmaus Life's otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Emmaus Life's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.
Things to note about Emmaus Life Sciences
Checking the ongoing alerts about Emmaus Life for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Emmaus Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Emmaus Life Sciences is not yet fully synchronised with the market data | |
Emmaus Life Sciences has some characteristics of a very speculative penny stock | |
Emmaus Life Sciences has a very high chance of going through financial distress in the upcoming years | |
Emmaus Life Sciences currently holds 4.65 M in liabilities. Emmaus Life Sciences has a current ratio of 0.14, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Emmaus Life until it has trouble settling it off, either with new capital or with free cash flow. So, Emmaus Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Emmaus Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Emmaus to invest in growth at high rates of return. When we think about Emmaus Life's use of debt, we should always consider it together with cash and equity. | |
The entity reported the previous year's revenue of 20.61 M. Net Loss for the year was (15.95 M) with profit before overhead, payroll, taxes, and interest of 17.3 M. | |
Emmaus Life Sciences currently holds about 982 K in cash with (1.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02. | |
Roughly 39.0% of the company shares are held by company insiders |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Consideration for investing in Emmaus OTC Stock
If you are still planning to invest in Emmaus Life Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Emmaus Life's history and understand the potential risks before investing.
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |